AutoImmune Inc. Reports 2009 Second Quarter Financi...(or other factors except as required by l...)

Website: http://www.autoimmuneinc.com

- Financial Chart Follows -

                                  AUTOIMMUNE INC.
                              STATEMENT OF OPERATIONS
                                    (Unaudited)

                                   Three months ended       Six months ended
                                        June 30,                June 30,
                                    2008        2009        2008        2009
                                    ----        ----        ----        ----

    Revenue                      $101,000    $184,000    $168,000    $288,000
                                 --------    --------    --------    --------


    Costs and expenses:
      Cost of goods sold           16,000      50,000      28,000      70,000
      Research and
       development                 48,000      30,000      90,000     101,000
      General and
       administrative             181,000     180,000     386,000     368,000
                                  -------     -------     -------     -------
        Total costs and
         expenses                 245,000     260,000     504,000     539,000
                                  -------     -------     -------     -------

    Interest income                60,000       8,000     144,000      17,000
                                   ------       -----     -------      ------
                                   60,000       8,000     144,000      17,000
                                   ------       -----     -------      ------

    Net loss                      (84,000)    (68,000)   (192,000)   (234,000)
      Net income (loss)
       attributable to
       noncontrolling
       interest              
'/>"/>
SOURCE  AutoImmune Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 
Related biology technology :

1. AutoImmune Inc. Reports 2009 First Quarter Financial Results
2. AutoImmune Inc. Reports 2008 Fourth Quarter and Year End Financial Results
3. Advances in Detection Technology Drive the European Autoimmune Disease Diagnostics Market
4. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
5. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
6. AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
7. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
8. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
9. Synthetech Reports First Quarter Fiscal 2010 Results
10. GenVec Reports Second Quarter 2009 Financial Results
11. InterMune Reports Second Quarter 2009 Financial Results and Business Highlights